Article(id=1329914786562814211, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, articleNumber=null, orderNo=null, doi=10.16522/j.cnki.cjph.2024.06.010, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1700150400000, receivedDateStr=2023-11-17, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005993738, onlineDateStr=2026-11-18, pubDate=1717948800000, pubDateStr=2024-06-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005993738, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005993738, creator=13701087609, updateTime=1795005993738, updator=13701087609, issue=Issue{id=1329914740324807335, tenantId=1146029695717560320, journalId=1319690259887390882, year='2024', volume='55', issue='6', pageStart='743', pageEnd='886', issueExtLink='null', onlineDate='null', pubDate='1717948800000', pubDateStr='2024-06-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005982713, creator='13701087609', updateTime=1795136155207, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330460723852981013, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330460723852981014, tenantId=1146029695717560320, journalId=1319690259887390882, issueId=1329914740324807335, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=804, endPage=810, ext={EN=ArticleExt(id=1329914786818666756, articleId=1329914786562814211, tenantId=1146029695717560320, journalId=1319690259887390882, language=EN, title=Preparation and in vitro Bioactivity Characterization of Recombinant Humanized Anti-MSLN Monoclonal Antibody, columnId=1322624454216238014, journalTitle=Chinese Journal of Pharmaceuticals, columnName=Paper, runingTitle=null, highlight=null, articleAbstract=

Mesothelin(MSLN) could be served as an important target for immunotherapy for its wide expression in a variety of solid tumors and less expression in normal mesothelial cells. In this study, a recombinant humanized IgG1 monoclonal antibody(rhMSLN mAb) sequence against MSLN with high affinity was constructed into the mammalian cell expression vector pcDNA3.4, and efficiently expressed by the Expi293F cell line. Then, the affinity of the antibody was assessed by surface plasmon resonance and flow cytometry at the molecular and cellular levels respectively. Lactate dehydrogenase(LDH) release assay was used to identify the antibody-dependent cellular cytotoxicity(ADCC) mediated by the antibody. The results showed that rhMSLN mAb could yield up to 70.2 mg/L under specific conditions by the Expi293F cell line. The affinity to recombinant MSLN was 7.02 nmol/L. The EC50 of ADCC against human gastric carcinoma cell line(NCI-N87 cell) was 2.48×10–3 μg/mL. This study provided explorative support for the development and production of biopharmaceuticals targeting MSLN.

, authors=Ying LU, Jianwei ZHU*, authorsList=Ying LU, Jianwei ZHU, authorCompany=null, correspAuthors=Jianwei ZHU, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914787066130693, articleId=1329914786562814211, tenantId=1146029695717560320, journalId=1319690259887390882, language=CN, title=抗人MSLN单克隆抗体的构建及体外活性表征, columnId=1322624454384010176, journalTitle=中国医药工业杂志, columnName=研究论文, runingTitle=null, highlight=null, articleAbstract=

由于间皮素(MSLN)在多种实体瘤中广泛表达而在正常间皮细胞上表达较低,可作为实体瘤治疗的重要靶点。研究旨在通过将具有较高亲和力的重组抗人MSLN IgG1型单克隆抗体(rhMSLN mAb)序列构建到哺乳动物细胞表达载体pcDNA3.4中,采用Expi293F细胞系高效表达重组单克隆抗体rhMSLN mAb,并采用表面等离子体共振和流式细胞术对其结合活性进行初步探究,采用乳酸脱氢酶(LDH)释放法鉴定其介导的抗体依赖的细胞毒作用(ADCC)。研究结果表明,rhMSLN mAb在Expi293F细胞中以特定条件进行瞬时表达的产量可达70.2 mg/L,与MSLN重组蛋白的亲和力为7.02 nmol/L,对人胃癌细胞(NCI-N87细胞)ADCC作用的EC50为2.48×10–3 μg/mL,为靶向MSLN生物技术药物开发及生产提供了前期探索性支持。

, authors=陆颖, 朱建伟*, authorsList=陆颖, 朱建伟, authorCompany=null, correspAuthors=朱建伟, authorNote=

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

, correspAuthorsNote=
朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=RSzQ69REFrteqFPtJuS8eg==, magXml=1+en4WMSUzi902CHg2oTzw==, pdfUrl=null, pdf=9nFRn5MMUmW5/C6c4Ww9Rw==, pdfFileSize=2597385, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=yHua67d+h6z80aNWbzSZvw==, mapNumber=null, fund=null)}, authors=[Author(id=1329914787376509194, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914787468783884, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787376509194, language=EN, stringName=Ying LU, firstName=Ying, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914787535892749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787376509194, language=CN, stringName=陆颖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240, bio={"content":"

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

"}, bioImg=null, bioContent=

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914787271651590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, xref=null, ext=[AuthorCompanyExt(id=1329914787280040199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329914787288428808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240)])]), Author(id=1329914787607195919, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jianweiz@sjtu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914787695276305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787607195919, language=EN, stringName=Jianwei ZHU, firstName=Jianwei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914787770773778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787607195919, language=CN, stringName=朱建伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914787271651590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, xref=null, ext=[AuthorCompanyExt(id=1329914787280040199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329914787288428808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240)])])], keywords=[Keyword(id=1329914787875631379, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=EN, orderNo=1, keyword=mesothelin), Keyword(id=1329914787942740244, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=EN, orderNo=2, keyword=monoclonal antibody), Keyword(id=1329914788014043413, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=EN, orderNo=3, keyword=Expi293F cell line), Keyword(id=1329914788089540886, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=EN, orderNo=4, keyword=antibody-dependent cellular cytotoxicity), Keyword(id=1329914788152455447, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=CN, orderNo=1, keyword=间皮素), Keyword(id=1329914788219564312, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=CN, orderNo=2, keyword=单克隆抗体), Keyword(id=1329914788290867481, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=CN, orderNo=3, keyword=Expi293F细胞), Keyword(id=1329914788353782042, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, language=CN, orderNo=4, keyword=抗体依赖的细胞毒作用)], refs=[Reference(id=1329914788454445339, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=CHANG K, PASTAN I.Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers [J].Proc Natl Acad Sci, 1996, 93(1): 136-140., articleTitle=null, refAbstract=null), Reference(id=1329914788525748508, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=CHANG K, PASTAN I, WILLINGHAM M C.Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium [J].Int J Cancer, 1992, 50(3): 373-381., articleTitle=null, refAbstract=null), Reference(id=1329914788588663069, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=YEO D, CASTELLETTI L, VAN ZANDWIJK N, et al.Hitting the bull’s-eye: mesothelin’s role as a biomarker and therapeutic target for malignant pleural mesothelioma [J].Cancers (Basel), 2021, 13(16): 3932., articleTitle=null, refAbstract=null), Reference(id=1329914788659966238, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=LV J, LI P.Mesothelin as a biomarker for targeted therapy [J].Biomark Res, 2019, 7(1): 18., articleTitle=null, refAbstract=null), Reference(id=1329914788718686495, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=AVULA L R, RUDLOFF M, EL-BEHAEDI S, et al.Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases [J].Mol Cancer Res, 2020, 18(2): 229-239., articleTitle=null, refAbstract=null), Reference(id=1329914788773212448, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=BHARADWAJ U, MARIN-MULLER C, LI M et al.Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression [J].Mol Cancer, 2011, 10(1): 106., articleTitle=null, refAbstract=null), Reference(id=1329914788844515617, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=SERVAIS E L, COLOVOS C, RODRIGUEZ L, et al.Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients [J].Clin Cancer Res, 2012, 18(9): 2478-2489., articleTitle=null, refAbstract=null), Reference(id=1329914788911624482, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIN S J, PARK S, KIM M H, et al.Mesothelin expression is a predictive factor for peritoneal recurrence in curatively resected stageⅢ gastric cancer [J].Oncologist, 2019, 24(11): e1108-e1114., articleTitle=null, refAbstract=null), Reference(id=1329914788970344739, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=RIZK N P, SERVAIS E L, TANG L H, et al.Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett’s associated esophageal adenocarcinoma[J].Cancer Epidemiol Biomarkers Prev, 2012, 21(3): 482-486., articleTitle=null, refAbstract=null), Reference(id=1329914789045842212, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=KACHALA S S, BOGRAD A J, VILLENA-VARGAS J,et al.Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma [J].Clin Cancer Res, 2014, 20(4): 1020-1028., articleTitle=null, refAbstract=null), Reference(id=1329914789117145381, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=GREVEN J A, BRETT T J.Production of eukaryotic glycoproteins for structural and functional studies using Expi293F cells [J].Curr Protoc, 2022, 2(8): e512., articleTitle=null, refAbstract=null), Reference(id=1329914789175865638, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=FENG Y, XIAO X D, ZHU Z Y, et al.A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity [J].Mol Cancer Ther, 2009, 8(5): 1113-1118., articleTitle=null, refAbstract=null), Reference(id=1329914789263946023, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=FAUST J R, HAMILL D, KOLB E A, et al.Mesothelin: an immunotherapeutic target beyond solid tumors [J].Cancers(Basel), 2022, 14(6): 1550., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1329914787271651590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, xref=null, ext=[AuthorCompanyExt(id=1329914787280040199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329914787288428808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240)])], figs=null, attaches=null, journal=Journal(id=1319689822849302687, delFlag=0, nameCn=中国医药工业杂志, nameEn=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, issn=1001-8255, eissn=null, cn=31-1243/R, coden=ZYGZEA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=etiWDuwx2KO274LHw88KJA==, journalPrice=null, startedYear=null, abbrevIsoEn=Chinese Journal of Pharmaceuticals, journalRemark=null, publicationField=null, createdTime=1792568172420, updatedTime=1792747450744, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=Z, firstLetterEn=Z, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=etiWDuwx2KO274LHw88KJA==, picEn=ip9NF4dK57AmNrCiZ6hmdw==, jcr=null, cjcr=null, exts=[JournalExt(id=1320441770761105589, language=CN, name=中国医药工业杂志, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450771, updatedTime=1792747450771, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""}), JournalExt(id=1320441770819825846, language=EN, name=Chinese Journal of Pharmaceuticals, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747450785, updatedTime=1792747450785, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=https://zgyygyauthor.cast.org.cn/webm, submissionEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionReviewUrl=https://zgyygyauthor.cast.org.cn/webm, submissionCeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, submissionAeEditorUrl=https://zgyygyeditor.cast.org.cn/webm, option={"copyright":""})], databaseList=null, tenantJournalId=1319690259887390882, websiteList=[Website(id=1319720771623174732, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/CN, language=CN, createTime=1792575551181, createBy=18614031015, updateTime=1792746040843, updateBy=18614031015, name=中国医药工业杂志-中文, tplId=1146099689490845704, title=中国医药工业杂志, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428487504769041, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=articleTextType, value=kx, createTime=1792982702375, updateTime=1792982702375, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487475408910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982702368, updateTime=1792982702368, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487538323476, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=grayFlag, value=0, createTime=1792982702383, updateTime=1792982702383, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487462825997, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982702365, updateTime=1792982702365, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487571877910, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=minRunFlag, value=0, createTime=1792982702391, updateTime=1792982702391, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487496380432, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/CN/file/pic, createTime=1792982702373, updateTime=1792982702373, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487563489301, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=silenceFlag, value=0, createTime=1792982702389, updateTime=1792982702389, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487483797519, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982702370, updateTime=1792982702370, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487517351954, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeColor, value=null, createTime=1792982702378, updateTime=1792982702378, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428487525740563, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771623174732, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982702380, updateTime=1792982702380, creator=18614031015, updator=18614031015)]), Website(id=1319720771702866512, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690259887390882, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/zgyygy/EN, language=EN, createTime=1792575551200, createBy=18614031015, updateTime=1792746037543, updateBy=18614031015, name=中国医药工业杂志-英文, tplId=1146101810881728533, title=Chinese Journal of Pharmaceuticals, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428509638111261, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=articleTextType, value=kx, createTime=1792982707652, updateTime=1792982707652, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509579391002, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=banner, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=i/3+mr8MqWvs6ArWn9VK7w==, createTime=1792982707638, updateTime=1792982707638, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509680054304, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=grayFlag, value=0, createTime=1792982707662, updateTime=1792982707662, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509566808089, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=logo, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic?fileId=7mfvc3zMp/tsQUIOlJrNFQ==, createTime=1792982707635, updateTime=1792982707635, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509701025826, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=minRunFlag, value=0, createTime=1792982707667, updateTime=1792982707667, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509629722652, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/zgyygy/EN/file/pic, createTime=1792982707650, updateTime=1792982707650, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509688442913, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=silenceFlag, value=0, createTime=1792982707664, updateTime=1792982707664, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509587779611, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982707640, updateTime=1792982707640, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509663277086, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeColor, value=null, createTime=1792982707658, updateTime=1792982707658, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428509671665695, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1319720771702866512, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982707660, updateTime=1792982707660, creator=18614031015, updator=18614031015)])], journalTitle=中国医药工业杂志, weixinUrl=null, journalUrl=http://www.cjph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=Chinese Journal of Pharmaceuticals, journalPhotoCn=etiWDuwx2KO274LHw88KJA==, journalPhotoEn=ip9NF4dK57AmNrCiZ6hmdw==, journalFirstLetter=Z, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.06.010, detailUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.06.010, pdfUrlCn=https://castjournals.cast.org.cn/joweb/zgyygy/CN/PDF/10.16522/j.cnki.cjph.2024.06.010, pdfUrlEn=https://castjournals.cast.org.cn/joweb/zgyygy/EN/PDF/10.16522/j.cnki.cjph.2024.06.010, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1717948800000, fullTextJson=null, articleText=null, reference=null)
收藏切换
抗人MSLN单克隆抗体的构建及体外活性表征
陆颖 , 朱建伟 *
中国医药工业杂志 | 研究论文 2024,55(6): 804-810
收起
收藏切换
中国医药工业杂志 |研究论文 2024 , 55 (6) : 804 -810
抗人MSLN单克隆抗体的构建及体外活性表征
全屏
[Author(id=1329914787376509194, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914787468783884, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787376509194, language=EN, stringName=Ying LU, firstName=Ying, middleName=null, lastName=LU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914787535892749, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787376509194, language=CN, stringName=陆颖, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240, bio={"content":"

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

"}, bioImg=null, bioContent=

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914787271651590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, xref=null, ext=[AuthorCompanyExt(id=1329914787280040199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329914787288428808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240)])]), Author(id=1329914787607195919, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=jianweiz@sjtu.edu.cn, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914787695276305, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787607195919, language=EN, stringName=Jianwei ZHU, firstName=Jianwei, middleName=null, lastName=ZHU, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914787770773778, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, authorId=1329914787607195919, language=CN, stringName=朱建伟, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914787271651590, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, xref=null, ext=[AuthorCompanyExt(id=1329914787280040199, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240), AuthorCompanyExt(id=1329914787288428808, tenantId=1146029695717560320, journalId=1319690259887390882, articleId=1329914786562814211, companyId=1329914787271651590, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240)])])]
陆颖, 朱建伟*
作者信息
  • 上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240
通讯作者:
朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
作者简介:

陆颖(1997—),女,硕士,专业方向:微生物与生化药学。

Preparation and in vitro Bioactivity Characterization of Recombinant Humanized Anti-MSLN Monoclonal Antibody
Ying LU, Jianwei ZHU*
Affiliations
  • Engineering Research Center of Cell & Therapeutic Antibody(MOE), School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240
出版时间: 2024-06-10 doi: 10.16522/j.cnki.cjph.2024.06.010
文章导航
收藏切换

由于间皮素(MSLN)在多种实体瘤中广泛表达而在正常间皮细胞上表达较低,可作为实体瘤治疗的重要靶点。研究旨在通过将具有较高亲和力的重组抗人MSLN IgG1型单克隆抗体(rhMSLN mAb)序列构建到哺乳动物细胞表达载体pcDNA3.4中,采用Expi293F细胞系高效表达重组单克隆抗体rhMSLN mAb,并采用表面等离子体共振和流式细胞术对其结合活性进行初步探究,采用乳酸脱氢酶(LDH)释放法鉴定其介导的抗体依赖的细胞毒作用(ADCC)。研究结果表明,rhMSLN mAb在Expi293F细胞中以特定条件进行瞬时表达的产量可达70.2 mg/L,与MSLN重组蛋白的亲和力为7.02 nmol/L,对人胃癌细胞(NCI-N87细胞)ADCC作用的EC50为2.48×10–3 μg/mL,为靶向MSLN生物技术药物开发及生产提供了前期探索性支持。

间皮素  /  单克隆抗体  /  Expi293F细胞  /  抗体依赖的细胞毒作用

Mesothelin(MSLN) could be served as an important target for immunotherapy for its wide expression in a variety of solid tumors and less expression in normal mesothelial cells. In this study, a recombinant humanized IgG1 monoclonal antibody(rhMSLN mAb) sequence against MSLN with high affinity was constructed into the mammalian cell expression vector pcDNA3.4, and efficiently expressed by the Expi293F cell line. Then, the affinity of the antibody was assessed by surface plasmon resonance and flow cytometry at the molecular and cellular levels respectively. Lactate dehydrogenase(LDH) release assay was used to identify the antibody-dependent cellular cytotoxicity(ADCC) mediated by the antibody. The results showed that rhMSLN mAb could yield up to 70.2 mg/L under specific conditions by the Expi293F cell line. The affinity to recombinant MSLN was 7.02 nmol/L. The EC50 of ADCC against human gastric carcinoma cell line(NCI-N87 cell) was 2.48×10–3 μg/mL. This study provided explorative support for the development and production of biopharmaceuticals targeting MSLN.

mesothelin  /  monoclonal antibody  /  Expi293F cell line  /  antibody-dependent cellular cytotoxicity
陆颖, 朱建伟. 抗人MSLN单克隆抗体的构建及体外活性表征. 中国医药工业杂志, 2024 , 55 (6) : 804 -810 . DOI: 10.16522/j.cnki.cjph.2024.06.010
Ying LU, Jianwei ZHU. Preparation and in vitro Bioactivity Characterization of Recombinant Humanized Anti-MSLN Monoclonal Antibody[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (6) : 804 -810 . DOI: 10.16522/j.cnki.cjph.2024.06.010

参考文献 引证文献
排序方式:
[1]
CHANG K, PASTAN I.Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers [J].Proc Natl Acad Sci, 1996, 93(1): 136-140.
[2]
CHANG K, PASTAN I, WILLINGHAM M C.Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium [J].Int J Cancer, 1992, 50(3): 373-381.
[3]
YEO D, CASTELLETTI L, VAN ZANDWIJK N, et al.Hitting the bull’s-eye: mesothelin’s role as a biomarker and therapeutic target for malignant pleural mesothelioma [J].Cancers (Basel), 2021, 13(16): 3932.
[4]
LV J, LI P.Mesothelin as a biomarker for targeted therapy [J].Biomark Res, 2019, 7(1): 18.
[5]
AVULA L R, RUDLOFF M, EL-BEHAEDI S, et al.Mesothelin enhances tumor vascularity in newly forming pancreatic peritoneal metastases [J].Mol Cancer Res, 2020, 18(2): 229-239.
[6]
BHARADWAJ U, MARIN-MULLER C, LI M et al.Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression [J].Mol Cancer, 2011, 10(1): 106.
[7]
SERVAIS E L, COLOVOS C, RODRIGUEZ L, et al.Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients [J].Clin Cancer Res, 2012, 18(9): 2478-2489.
[8]
SHIN S J, PARK S, KIM M H, et al.Mesothelin expression is a predictive factor for peritoneal recurrence in curatively resected stageⅢ gastric cancer [J].Oncologist, 2019, 24(11): e1108-e1114.
[9]
RIZK N P, SERVAIS E L, TANG L H, et al.Tissue and serum mesothelin are potential markers of neoplastic progression in Barrett’s associated esophageal adenocarcinoma[J].Cancer Epidemiol Biomarkers Prev, 2012, 21(3): 482-486.
[10]
KACHALA S S, BOGRAD A J, VILLENA-VARGAS J,et al.Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma [J].Clin Cancer Res, 2014, 20(4): 1020-1028.
[11]
GREVEN J A, BRETT T J.Production of eukaryotic glycoproteins for structural and functional studies using Expi293F cells [J].Curr Protoc, 2022, 2(8): e512.
[12]
FENG Y, XIAO X D, ZHU Z Y, et al.A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity [J].Mol Cancer Ther, 2009, 8(5): 1113-1118.
[13]
FAUST J R, HAMILL D, KOLB E A, et al.Mesothelin: an immunotherapeutic target beyond solid tumors [J].Cancers(Basel), 2022, 14(6): 1550.
2024年第55卷第6期
28
6
0
引用本文
BibTeX
文章信息
doi: 10.16522/j.cnki.cjph.2024.06.010
  • 接收时间:2023-11-17
  • 首发时间:2026-11-18
  • 出版时间:2024-06-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2023-11-17
基金
作者信息
    上海交通大学药学院,细胞工程与抗体药物教育部工程研究中心,上海 200240

通讯作者:

朱建伟(1956—),男,博士,讲席教授,从事生物技术药物的研发。E-mail:
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/zgyygy/CN/10.16522/j.cnki.cjph.2024.06.010
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏